FindTrial
Sign In

Brief Pain Inventory

DIAGNOSTIC_TEST2 trials

Sponsors

Washington University School of Medicine, LMU Klinikum

Conditions

Chemotherapy-induced Peripheral NeuropathyFacioscapulohumeral Muscular Dystrophy 1HealthyInclusion Body Myositis, SporadicMyotonic Dystrophy Type 1 (DM1)Myotonic Dystrophy Type 2Pompe Disease (Late-onset)Spinal Muscular Atrophy Type 3

Unknown Phase

A New Method for Identifying Sensory Changes in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)
CompletedNCT03687970
Washington University School of MedicineChemotherapy-induced Peripheral Neuropathy
Start: 2018-09-17End: 2019-09-17Updated: 2021-05-19
Musculoskeletal Nociceptive Pain in Participants With Neuromuscular Disorders
CompletedNCT04907162
LMU KlinikumFacioscapulohumeral Muscular Dystrophy 1, Healthy, Inclusion Body Myositis, Sporadic +4
Start: 2021-04-15End: 2022-08-15Updated: 2022-08-24

Related Papers

Characterization of Patients With and Without Painful Peripheral Neuropathy After Receiving Neurotoxic Chemotherapy: Traditional Quantitative Sensory Testing vs C-Fiber and Aδ-Fiber Selective Diode Laser Stimulation.
2021-12-096 citations